U.S. Food and Drug Administration vs U.S. Securities and Exchange Commission — Velocity
How often tier-1 publications and AI engines cite each source per week — the most volatile sub-score.
U.S. Securities and Exchange Commission outscores U.S. Food and Drug Administration on Citation Velocity by 1 points (A+ · 95 vs A · 94).
U.S. Food and Drug Administration
Cited daily by health press + AI engines; FDA decisions are market-moving.
U.S. Securities and Exchange Commission
Cited by every financial news outlet; primary source for HoldLens-class downstream tools.
Global rank · Velocity
Why these Velocity scores
Cited daily by health press + AI engines; FDA decisions are market-moving.
Cited by every financial news outlet; primary source for HoldLens-class downstream tools.
Signals behind the Velocity score
- Drug-approval cycleMajor FDA decisions drive same-day citation surges.
- Downstream citationsReuters, Bloomberg, FT all cite SEC daily.
Other dimensions for U.S. Food and Drug Administration vs U.S. Securities and Exchange Commission
Other Velocity comparisons
Sources & references
Every score on this page is read from the two publications below and graded against the published rubric. No score is bought, estimated or supplied by the source being scored.
- Source evaluated — U.S. Food and Drug Administration (fda.gov) · verified · full scoring record
- Source evaluated — U.S. Securities and Exchange Commission (sec.gov) · verified · full scoring record
- Scoring rubric — SourceScore Index, Citation Discipline, Modern Reference, Citation Velocity (methodology v0.1)
- Machine-readable record — /api/compare/fda-gov-vs-sec-gov/velocity.json